Brief: Lumiradx Lab Analysis Confirms Its Covid-19 Antigen Test Detects The Omicron Variant
14/01/2022 11:38
Jan 14 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX LAB ANALYSIS CONFIRMS ITS COVID-19 ANTIGEN TEST DETECTS THE
OMICRON
VARIANT
* LUMIRADX - IN-HOUSE WET TESTING WITH LIVE OMICRON VIRUS DEMONSTRATED THAT
LUMIRADX SARS-COV-2 ANTIGEN TEST DETECTS THE VARIANT WITH COMPARABLE SENSITIVITY
TO OTHERS
Source text for Eikon: ID:nPn3rVgPYa
Further company coverage: LMDX.O
(R)
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing